# Diastolic Heart Failure in HIV-1 infection

> **NIH NIH R01** · UNIVERSITY OF NEBRASKA MEDICAL CENTER · 2022 · $625,186

## Abstract

Abstract:
Contemporary estimates suggest that more than 40% of people living with chronic HIV-1 infection (PLWH) have
diastolic heart failure (dHF), a harbinger for adverse clinical outcomes including pulmonary abnormalities,
frequent hospitalizations, and sudden death. To date, the molecular causes for dHF in PLWH remain poorly
understood. This paucity of information and a lack of treatment options have prompted the OAR to list “Strategies
to Prevent and Treat HIV-Associated Heart Diseases” as areas of high priority for HIV research. We hypothesize
that that “elevation of the cytotoxic glycolysis metabolite, methylglyoxal (MG) is a primary cause for dHF
development in PLWH.” This elevation in MG is arising from HIV-1 induce upregulation of glycolysis in infected
immunocytes followed by ischemia-induced increase in glycolysis in vascular cells and cardiac myocytes. This
multi-PI project brings together the expertise of Drs. Keshore R. Bidasee (M-PI, heart failure) and Santhi Gorantla
(M-PI, humanized mice and HIV-1 infection) with assistance from Dr. Prasanta Dash (HIV-1 eradication and
cardiovascular complications), to (1) Define pathobiological trajectories of dHF in relation to MG levels in HIV-1
infected Hu-mice with and with ARD treatment; (2) Characterize mechanisms by which MG increases in HIV-I
infected immunocytes and in myocytes, macrophages and vascular cells under with and without ARD and
hypoxia (3) Show that lowering MG will blunt dHF in HIV-infected Hu-mice with and without ARD.
Accomplishments of these aims will not only define a novel link between glycolysis and early-onset dHF in the
setting of HIV-1 infection, but the data could pave the way for the development of urgently needed therapeutics
to mitigate this disease in PLWH.

## Key facts

- **NIH application ID:** 10491524
- **Project number:** 1R01HL164306-01
- **Recipient organization:** UNIVERSITY OF NEBRASKA MEDICAL CENTER
- **Principal Investigator:** KESHORE R BIDASEE
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $625,186
- **Award type:** 1
- **Project period:** 2022-07-15 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10491524

## Citation

> US National Institutes of Health, RePORTER application 10491524, Diastolic Heart Failure in HIV-1 infection (1R01HL164306-01). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10491524. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*